BLUIX
Price
$16.09
Change
-$0.06 (-0.37%)
Updated
Sep 25 closing price
Net Assets
N/A
RLBAX
Price
$38.04
Change
-$0.16 (-0.42%)
Updated
Sep 25 closing price
Net Assets
263.26B
Interact to see
Advertisement

BLUIX vs RLBAX

Header iconBLUIX vs RLBAX Comparison
Open Charts BLUIX vs RLBAXBanner chart's image
Blueprint Adaptive Growth Allc Instl
Price$16.09
Change-$0.06 (-0.37%)
VolumeN/A
Net AssetsN/A
American Funds American Balanced R1
Price$38.04
Change-$0.16 (-0.42%)
VolumeN/A
Net Assets263.26B
BLUIX vs RLBAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BLUIX vs. RLBAX commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLUIX is a Hold and RLBAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBAX pays higher dividends than BLUIX: RLBAX (1.15) vs BLUIX (0.45). BLUIX was incepted earlier than RLBAX: BLUIX (5 years) vs RLBAX (23 years). RLBAX (1.31) and BLUIX (1.27) have similar cost to investors . BLUIX is a more actively managed with annual turnover of: 151.00 vs. RLBAX (44.00). RLBAX has a lower initial minimum investment than BLUIX: RLBAX (250) vs BLUIX (5000). BLUIX annual gain was more profitable for investors over the last year : 9.85 vs. RLBAX (7.29). BLUIX return over 5 years is better than : 51.24 vs. RLBAX (39.63).
BLUIXRLBAXBLUIX / RLBAX
Total Expense Ratio1.311.31100%
Annual Report Gross Expense Ratio1.271.3197%
Fund Existence5 years23 years-
Gain YTD9.34312.23676%
Front LoadN/AN/A-
Min. Initial Investment50002502,000%
Min. Initial Investment IRAN/AN/A-
Net AssetsN/A263B-
Annual Yield % from dividends0.451.1539%
Returns for 1 year9.857.29135%
Returns for 3 years45.2847.3096%
Returns for 5 years51.2439.63129%
Returns for 10 yearsN/A74.58-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TARA4.290.21
+5.15%
Protara Therapeutics
AAPG37.830.42
+1.12%
Ascentage Pharma Group
BLRX3.790.01
+0.26%
BioLineRx Ltd
TEF5.01-0.07
-1.38%
Telefonica SA
TIPT20.18-3.62
-15.21%
Tiptree